Consequently, dysregulation of IL-6 emerges as a substantial factor in various neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD) (71, 72), and Huntington’s disease (HD) (30, 73, 74), Multiple Sclerosis (MS) (75, 76), Amyotrophic Lateral Sclerosis (ALS) (77, 78) an others. This evidence concerns the gene IL6 and juvenile Huntington disease.